Clinical Trial Update: P4 Peptide in Community Acquired Pneumonia

View source ↗

Summary

A trial evaluating P4 Peptide for community-acquired pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• P4 Peptide (P4 peptide)

Snippet

Sponsor: Liverpool University Hospitals NHS Foundation Trust | Conditions: Pneumonia | Status: COMPLETED